Download PDF
Drug Res (Stuttg) 2023; 73(01): 17-22
DOI: 10.1055/a-1936-8412
Review

Effect of Nigella Sativa in Improving Blood Glucose Level in T2DM: Systematic Literature Review of Randomized Control Trials

Ilma
Farazul Hoda
1   Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
,
Afifa Khanam
1   Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
,
Mehak Thareja
1   Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
,
Mawrah Arshad
1   Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
,
Mohd Ahtar
1   Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
,
Abul Kalam Najmi
1   Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
› Author Affiliations Funding This research did not receive any external funding.
› Further Information
Also available at
    Permissions and Reprints

Abstract

Background Diabetes mellitus is a highly prevalent condition that affects people of all ages, races, and genders. Medicinal herbs have received a lot of attention from researchers, and they have suggested it to be a good adjuvant to oral diabetes medications because of their combined effects.

Objectives The purpose of this systematic review is to summarize the available evidences and literature of Randomized Control Trials (RCTs) on Nigella sativa (NS) in the management of Type 2 Diabetes Mellitus (T2DM).

Methods A computerised database search was performed to obtain the relevant clinical trial studies. We searched the following PubMed and Google Scholar databases. Randomized controlled trials (RCTs) comparing NS versus any treatment for the management of T2DM in adults were eligible for inclusion.

Results A total of 7 articles were retrieved for interpretation, complete assessment and data extraction in this systematic review. This systematic review seeks to give thorough information on the effects of NS on glucose and insulin profile status in patients with T2DM.

Interpretation & Conclusion Different mechanisms are proposed which contribute to the anti-diabetic activity of NS. Various outcome parameters evaluated demonstrate a significant improvement in the management of T2DM and its complications upon intervention with NS.

Key words

nigella sativa - black cumin - kalonji - thymoquinone - type 2 diabetes mellitus - hypoglycaemia - blood glucose - fasting blood glucose - HbA1c


Publication History

Received: 13 June 2022

Accepted: 03 September 2022

Article published online:
27 September 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Hussain S, Habib A, Singh A, Akhtar M, Najmi AK.. Prevalence of depression among type 2 diabetes mellitus patients in India: A meta-analysis. Psychiatry research 2018; Dec 1 270: 264-73
    CrossrefPubMedGoogle Scholar
  • 2 Hussain S, Khan MS, Jamali MC, Siddiqui AN, Gupta G, Hussain MS, Husain FM.. Impact of bariatric surgery in reducing macrovascular complications in severely obese T2DM patients. Obesity Surgery 2021; May 31: 1929-36
    CrossrefPubMedGoogle Scholar
  • 3 Zheng Y, Ley SH, Hu FB.. Global etiology and epidemiology of type 2 diabetes mellitus and its complications. Nature reviews endocrinology 2018; Feb 14: 88-98
    CrossrefPubMedGoogle Scholar
  • 4 Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw JE, Makaroff LE.. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes research and clinical practice 2017; Jun 1 128: 40-50
    CrossrefPubMedGoogle Scholar
  • 5 Unnikrishnan R, Pradeepa R, Joshi SR, Mohan V.. Type 2 diabetes: demystifying the global epidemic. Diabetes. 2017; Jun 1 66: 1432-1442
    CrossrefPubMedGoogle Scholar
  • 6 Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K.. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes research and clinical practice 2002; Jan 1 55: 65-85
    CrossrefPubMedGoogle Scholar
  • 7 Rang and Dale’s pharmacology, seventh edition
    PubMed
  • 8 Boden G.. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 1997; Jan 1 46: 3-10
    CrossrefPubMedGoogle Scholar
  • 9 American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes care. 2017 Jan 1;40(Supplement_1):S11-24
    PubMed
  • 10 Östenson CG.. The pathophysiology of type 2 diabetes mellitus: an overview. Acta Physiologica Scandinavica 2001; Mar 171: 241-247
    CrossrefPubMedGoogle Scholar
  • 11 Katzung and Trevor’s Pharmacology Examination and Board Review, 12th edition
    PubMed
  • 12 Hamdan A, Haji Idrus R, Mokhtar MH.. Effects of Nigella sativa on type-2 diabetes mellitus: a systematic review. International journal of environmental research and public health 2019; Jan 16: 4911
    CrossrefPubMedGoogle Scholar
  • 13 Basic and clinical pharmacology by Bertram G. Katzung and Anthony J. Trevor, 13th edition
    PubMed
  • 14 Begum GS, Jabeen A, Rahman A.. Assessing The Glycemic Control in Type 2 Diabetic Patients by Comparing Glycosylated Hemoglobin Levels (Hba1c) With Fasting and Postprandial Glucose. Journal of Biotechnology and Biochemistry 2018; 4: 54-57
    PubMedGoogle Scholar
  • 15 Bardini G, Rotella CM, Giannini S.. Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro-and macrovascular complications. The review of diabetic studies: RDS 2012; 9: 82
    CrossrefPubMedGoogle Scholar
  • 16 Hadi S, Daryabeygi-Khotbehsara R, Mirmiran P, McVicar J, Hadi V, Soleimani D, Askari G.. Effect of Nigella sativa oil extract on cardiometabolic risk factors in type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial. Phytotherapy Research 2021; Jul 35: 3747-55.
    CrossrefPubMedGoogle Scholar
  • 17 Li GQ, Kam A, Wong KH, Zhou X, Omar EA, Alqahtani A, Li KM, Razmovski-Naumovski V, Chan K.. Herbal medicines for the management of diabetes. Diabetes 2013; 396-413
    PubMedGoogle Scholar
  • 18 Mohtashami A, Entezari MH.. Effects of Nigella sativa supplementation on blood parameters and anthropometric indices in adults: A systematic review on clinical trials. Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences 2016; 21
    PubMedGoogle Scholar
  • 19 Maideen NM.. Antidiabetic Activity of Nigella Sativa (Black Seeds) and Its Active Constituent (Thymoquinone): A Review of Human and Experimental Animal Studies. Chonnam Medical Journal 2021; Sep 57: 169
    CrossrefPubMedGoogle Scholar
  • 20 Ghorbani A.. Best herbs for managing diabetes: a review of clinical studies. Brazilian Journal of Pharmaceutical Sciences 2013; Sep 49: 413-22
    CrossrefPubMedGoogle Scholar
  • 21 Darakhshan S, Tahvilian R, Colagar AH, Babolsar I.. Nigella sativa: A plant with multiple therapeutic implications. International Journal of Pharmacognosy 2015; 2: 190-214
    PubMedGoogle Scholar
  • 22 Benhaddou-Andaloussi A, Martineau LC, Vallerand D, Haddad Y, Afshar A, Settaf A, Haddad PS.. Multiple molecular targets underlie the antidiabetic effect of Nigella sativa seed extract in skeletal muscle, adipocyte and liver cells. Diabetes Obes Metab 2010; 12: 148-157
    CrossrefPubMedGoogle Scholar
  • 23 Fararh KM, Atoji Y, Shimizu Y, Shiina T, Nikami H, Takewaki T.. Mechanisms of the hypoglycaemic and immunopotentiating effects of Nigella sativa L. oil in streptozotocin-induced diabetic hamsters. Research in veterinary science 2004; Oct 1 77: 123-129
    CrossrefPubMedGoogle Scholar
  • 24 Meddah B, Ducroc R, Faouzi ME, Eto B, Mahraoui L, Benhaddou-Andaloussi A, Martineau LC, Cherrah Y, Haddad PS.. Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats. Journal of ethnopharmacology 2009; Jan 30 121: 419-424
    CrossrefPubMedGoogle Scholar
  • 25 Le PM, Benhaddou-Andaloussi A, Elimadi A, Settaf A, Cherrah Y, Haddad PS.. The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat. Journal of ethnopharmacology 2004; Oct 1 94: 251-259
    CrossrefPubMedGoogle Scholar
  • 26 Liberati A, Altman DG, Tetzlaff J. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clin Res Ed) 2009; 339 (jul21 1) b2700
    CrossrefPubMedGoogle Scholar
  • 27 Singh A, Danda D, Hussain S, Najmi AK, Mathew A, Goel R, Lakhan SE, Tajudheen B, Antony B.. Efficacy and safety of tocilizumab in treatment of Takayasu arteritis: A systematic review of randomized controlled trials. Modern Rheumatology 2021; Jan 2 31: 197-204
    CrossrefPubMedGoogle Scholar
  • 28 Hussain S, Singh A, Akhtar M, Najmi AK.. Vitamin D supplementation for the management of knee osteoarthritis: a systematic review of randomized controlled trials. Rheumatology international 2017; Sep 37: 1489-98
    CrossrefPubMedGoogle Scholar
  • 29 Hussain S, Singh A, Alshammari TM, Habib A, Hussain MS, Jha R, Akhtar M, Najmi AK.. Nicotinamide therapy in dialysis patients: A systematic review of randomized controlled trials. Saudi Journal of Kidney Diseases and Transplantation 2020; Sep 1 31: 883
    CrossrefPubMedGoogle Scholar
  • 30 Kaatabi H, Bamosa AO, Badar A, Al-Elq A, Abou-Hozaifa B, Lebda F, Al-Khadra A, Al-Almaie S.. Nigella sativa improves glycemic control and ameliorates oxidative stress in patients with type 2 diabetes mellitus: placebo controlled participant blinded clinical trial. PloS one 2015; Feb 23 10: e0113486
    CrossrefPubMedGoogle Scholar
  • 31 Heshmati J, Namazi N, Memarzadeh MR, Taghizadeh M, Kolahdooz F.. Nigella sativa oil affects glucose metabolism and lipid concentrations in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Food Research International 2015; Apr 1 70: 87-93
    CrossrefPubMedGoogle Scholar
  • 32 Hosseini MS, Mirkarimi SA, Amini M, Mohtashami R, Kianbakht S, FALLAH HH.. Effects of Nigella sativa L. seed oil in type II diabetic Patients: A randomized, double-blind, placebo-controlled clinical trial.
    PubMedGoogle Scholar
  • 33 Najmi AH, Nasiruddin MO, Khan RA, Haque SF.. Therapeutic effect of Nigella sativa in patients of poor glycemic control. Asian J Pharm. Clin Res 2012; Jul 5: 224-228
    PubMedGoogle Scholar
  • 34 Bamosa AO, Kaatabi H, Lebdaa FM, Elq AM, Al-Sultanb A.. Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitus. Indian J Physiol Pharmacol 2010; Oct 1 54: 344-354
    PubMedGoogle Scholar
  • 35 Houcher Z, Boudiaf K, Benboubetra M, Houcher B.. Effects of methanolic extract and commercial oil of Nigella sativa L. on blood glucose and antioxidant capacity in Alloxan-induced diabetic rats. Pteridines 2007; Feb 1 18: 8-18
    CrossrefPubMedGoogle Scholar
  • 36 Kooshki A, Tofighiyan T, Rastgoo N, Rakhshani MH, Miri M.. Effect of Nigella sativa oil supplement on risk factors for cardiovascular diseases in patients with type 2 diabetes mellitus. Phytotherapy Research 2020; Oct 34: 2706-11
    CrossrefPubMedGoogle Scholar